{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:24:17Z","timestamp":1793647457173,"version":"4.5.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijrobp.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:15:55Z","timestamp":1715440555000},"page":"805-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4268-3079","authenticated-orcid":false,"given":"Lachlan","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Hutcheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Corry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Henson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Rischin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.05.005_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0002","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2016.03.017","article-title":"Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: A substudy of randomized trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART)","volume":"97","author":"Ringash","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0003","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial","volume":"28","author":"Rischin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hed.23561","article-title":"Outcomes toolbox for head and neck cancer research","volume":"37","author":"Ringash","year":"2015","journal-title":"Head & Neck"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hed.10367","article-title":"Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatients","volume":"26","author":"List","year":"2004","journal-title":"Head & Neck"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0006","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1200\/JCO.2000.18.4.877","article-title":"How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?","volume":"18","author":"List","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.oraloncology.2019.05.016","article-title":"Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment","volume":"95","author":"Windon","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0008","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/cncr.31920","article-title":"Priorities, concerns, and regret among patients with head and neck cancer","volume":"125","author":"Windon","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow028","article-title":"Patient-reported outcome measures in dysphagia: A systematic review of instrument development and validation","volume":"30","author":"Patel","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0010","first-page":"870","article-title":"The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: The M. D. Anderson dysphagia inventory","volume":"127","author":"Chen","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALATE HPV): An open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0012","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN cancer research group trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0013","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): An open-label, phase 2, randomised trial","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0014","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy versus transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: The ORATOR2 phase 2 randomized clinical trial","author":"Palma","year":"2022","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0015","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0016","unstructured":"National Institutes of Health. Post-operative adjuvant treatment for HPV-positive tumours (PATHOS). Available at: https:\/\/ClinicalTrials.gov\/show\/NCT02215265. Accessed May 12, 2022."},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0017","unstructured":"Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims federal register. Available at:https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Accessed August 31, 2022."},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0018","series-title":"Guidelines for Developing Questionnaire Modules","author":"Johnson","year":"2011"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0019","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","article-title":"ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research","volume":"22","author":"Reeve","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0020","series-title":"TheM.D. Anderson Dysphagia Inventory: Development and Validation of a Disease-Specific Instrument","author":"Chen","year":"1999"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0021","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00433916","article-title":"Functional Assessment of Cancer Therapy (FACT-G): Non-response to individual questions","volume":"5","author":"Fairclough","year":"1996","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0022","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<679::AID-SIM814>3.0.CO;2-X","article-title":"Incomplete quality of life data in randomized trials: Missing items","volume":"17","author":"Fayers","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ijrobp.2016.06.010","article-title":"Long-term, prospective performance of the MD anderson dysphagia inventory in \u201clow-intermediate risk\u201d oropharyngeal carcinoma after intensity modulated radiation therapy","volume":"97","author":"Goepfert","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0026","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/cncr.31957","article-title":"Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing","volume":"125","author":"Grant","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0027","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ijrobp.2022.07.380","article-title":"Reduced aspiration rates for 50 Gy postoperative radiation in HPV-associated oropharynx cancer in E3311: A trial of the ECOG-ACRIN Cancer Research Group","volume":"114","author":"Hutcheson","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0028","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: Long-term results of the ORATOR trial","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0029","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk HPV-associated oropharyngeal cancer (TROG 12.01) - a Trans-Tasman Radiation Oncology Group study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0030","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1111\/ajco.12580","article-title":"Ovarian cancer study dropouts had worse health-related quality of life and psychosocial symptoms at baseline and over time","volume":"13","author":"Mercieca-Bebber","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0031","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2017.21903","article-title":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO extension","volume":"319","author":"Calvert","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010938","article-title":"Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: A systematic review","volume":"6","author":"Mercieca-Bebber","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0033","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/ajco.13384","article-title":"Validity and reliability of the MD Anderson dysphagia inventory in English and Chinese in head and neck cancer patients","volume":"16","author":"Yee","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0034","article-title":"Validity and reliability of an Arabic version of MD Anderson Dysphagia Inventory (MDADI)","author":"Alsubaie","year":"2021","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00455-011-9375-8","article-title":"Validation of the Swedish M.D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbances","volume":"27","author":"Carlsson","year":"2012","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0036","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1055\/s-0041-1735566","article-title":"Translation and validation of the Indonesian MD Anderson Dysphagia Inventory (MDADI) in head and neck cancer patients with swallowing disorders","volume":"26","author":"Fakhriani","year":"2022","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0037","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00455-012-9409-x","article-title":"Validation and application of the M.D. Anderson Dysphagia Inventory in patients treated for head and neck cancer in Brazil","volume":"28","author":"Guedes","year":"2013","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0038","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00455-017-9785-3","article-title":"Cross-cultural translation, adaptation and reliability of the Danish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer","volume":"32","author":"Hajd\u00fa","year":"2017","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0039","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5535\/arm.2013.37.4.479","article-title":"Validity and reliability of the Korean version of the MD Anderson Dysphagia Inventory for head and neck cancer patients","volume":"37","author":"Kwon","year":"2013","journal-title":"Ann Rehabil Med"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0040","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1007\/s00405-020-06100-w","article-title":"Validity and reliability of a French version of M.D. Anderson Dysphagia Inventory","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0041","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00455-021-10281-9","article-title":"Psychometric properties of the MDADI\u2014a preliminary study of whether less is truly more?","volume":"37","author":"Lin","year":"2022","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0042","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00455-017-9842-y","article-title":"Reliability and validity of the MD Anderson Dysphagia Inventory among Japanese patients","volume":"33","author":"Matsuda","year":"2018","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0043","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hed.25478","article-title":"Translation and validation of the MD Anderson Dysphagia Inventory (MDADI) for Spanish-speaking patients","volume":"41","author":"Montes-Jovellar","year":"2019","journal-title":"Head & Neck"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0044","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00455-011-9327-3","article-title":"Quality of life in oncological patients with oropharyngeal dysphagia: Validity and reliability of the Dutch version of the MD Anderson Dysphagia Inventory and the Deglutition Handicap Index","volume":"26","author":"Speyer","year":"2011","journal-title":"Dysphagia"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0045","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/NCC.0000000000000397","article-title":"Psychometric properties of the Chinese version of the M.D. Anderson Dysphagia Inventory for head and neck cancer patients","volume":"40","author":"Zhang","year":"2017","journal-title":"Cancer Nursing"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0046","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000504222","article-title":"Validation of the Dutch version of the M.D. Anderson Dysphagia Inventory for neurogenic patients","volume":"73","author":"Samuels","year":"2021","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0047","series-title":"Dictionary of Quality of Life and Health Outcomes Measurment","year":"2015"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0048","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1207\/S15327752JPA8001_18","article-title":"Starting at the beginning: An introduction to coefficient alpha and internal consistency","volume":"80","author":"Streiner","year":"2003","journal-title":"J Pers Assess"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0049","series-title":"Quality of Life: The Assessment, Analysis and Reporting of Patient-reported Outcomes","author":"Fayers","year":"2015"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0050","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S","article-title":"The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity","volume":"77","author":"List","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0051","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/h0046016","article-title":"Convergent and discriminant validation by the multitrait-multimethod matrix","volume":"56","author":"Campbell","year":"1959","journal-title":"Psychological Bulletin"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0052","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ijrobp.2017.08.004","article-title":"Quantitative evaluation of head and neck cancer treatment-related dysphagia in the development of a personalized treatment deintensification paradigm","volume":"99","author":"Quon","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0053","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cncr.30283","article-title":"Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation","volume":"123","author":"Hutcheson","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0054","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/cncr.34079","article-title":"Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2","volume":"128","author":"Hutcheson","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","article-title":"Quality criteria were proposed for measurement properties of health status questionnaires","volume":"60","author":"Terwee","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhsa.2018.12.006","article-title":"A comparison of PROMIS UE versus PF: Correlation to PROMIS PI and depression, ceiling and floor effects, and time to completion","volume":"44","author":"Bernstein","year":"2019","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0057","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01593882","article-title":"Individual-patient monitoring in clinical practice: Are available health status surveys adequate?","volume":"4","author":"McHorney","year":"1995","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0058","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/lary.25778","article-title":"What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?","volume":"126","author":"Hutcheson","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0059","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1015291021312","article-title":"Assessing health status and quality-of-life instruments: Attributes and review criteria","volume":"11","author":"Aaronson","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0060","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","article-title":"Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"48","author":"Cocks","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0061","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30","volume":"29","author":"Cocks","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0062","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ebmental-2020-300164","article-title":"Mind the methods of determining minimal important differences: three critical issues to consider","volume":"24","author":"Devji","year":"2021","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0063","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cncr.22799","article-title":"Interpreting clinically significant changes in patient-reported outcomes","volume":"110","author":"Ringash","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0064","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1586\/erp.11.9","article-title":"A point of minimal important difference (MID): A critique of terminology and methods","volume":"11","author":"King","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.ijrobp.2024.05.005_bib0066","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1470-2045(23)00265-6","article-title":"Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): A phase 3, multicentre, randomised, controlled trial","volume":"24","author":"Nutting","year":"2023","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162400628X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162400628X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:31:00Z","timestamp":1727224260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162400628X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S036030162400628X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.05.005","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}